FENC
Fennec Pharmaceuticals Inc

1,321
Mkt Cap
$264.93M
Volume
66,922.00
52W High
$9.92
52W Low
$4.68
PE Ratio
-32.61
FENC Fundamentals
Price
$7.43
Prev Close
$7.76
Open
$7.64
50D MA
$7.94
Beta
0.89
Avg. Volume
117,699.44
EPS (Annual)
-$0.016
P/B
-48.48
Rev/Employee
$1.49M
$158.54
Loading...
Loading...
News
all
press releases
Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates
Gossamer Bio (GOSS) delivered earnings and revenue surprises of -7.14% and +81.52%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·19h ago
News Placeholder
More News
News Placeholder
Adherex Technologies (NASDAQ:FENC) Cut to Buy at Wall Street Zen
Wall Street Zen cut Adherex Technologies from a "strong-buy" rating to a "buy" rating in a research report on Saturday...
MarketBeat·4d ago
News Placeholder
Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates
Gyre Therapeutics, Inc. (GYRE) delivered earnings and revenue surprises of -50.00% and +2.17%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) have received an average rating of "Moderate Buy" from the seven ratings firms that are covering the firm, MarketBeat.com reports...
MarketBeat·11d ago
News Placeholder
Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline
Gossamer Bio (GOSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·13d ago
News Placeholder
Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release
Adherex Technologies (FENC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·16d ago
News Placeholder
Zymeworks Inc. (ZYME) Reports Q4 Loss, Lags Revenue Estimates
Zymeworks (ZYME) delivered earnings and revenue surprises of -58.64% and -88.23%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·16d ago
News Placeholder
Adherex Technologies (FENC) to Release Quarterly Earnings on Monday
Adherex Technologies (NASDAQ:FENC) will be releasing its Q4 2025 earnings before the market opens on Monday, March 9. (View Earnings Report at...
MarketBeat·16d ago
News Placeholder
Certara, Inc. (CERT) Q4 Earnings Lag Estimates
Certara (CERT) delivered earnings and revenue surprises of -20.57% and +0.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·20d ago
News Placeholder
Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates
Apellis Pharmaceuticals (APLS) delivered earnings and revenue surprises of +219.14% and +2.85%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·22d ago
<
1
2
...
>

Latest FENC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.